TITLE

AVITA GETS AU$2M FROM US MILITARY TO SPEED DEVICE APPROVAL

PUB. DATE
July 2009
SOURCE
Worldwide Biotech;Jul2009, Vol. 21 Issue 7, p2
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports that $1.45 million have been given by the U.S. Armed Forces Institute of Regenerative Medicine (AFIRM) to Avita Medical Ltd. The money will be used to speed up the approval of the ReCell Autologous Cell Harvesting device of Avita in the U.S. It is noted that the device will be used by AFIRM on wounded soldiers.
ACCESSION #
42633240

 

Related Articles

  • Avita introduces ReCell in Arabian Peninsula.  // Medical Device Daily;5/27/2011, Vol. 15 Issue 103, p2 

    The article reports on the introduction by Avita Medical of its ReCell Spray-On-Skin to the health care market in the Arabian Peninsula.

  • Skin trade: partnership seeks greater understanding of wound healing device.  // Engineer (Online Edition);8/20/2015, p1 

    The article reports on the partnership of Huddersfield University in England and regenerative medicine company Avita Medical Ltd. to explore the mechanism of Regenerative Epithelial Suspension (RES) to better understand its ability to treat cutaneous anomalies including burns.

  • Study Demonstrates That Avita Medical's ReCell(r) Spray-On Skin(tm) "Has Potentially Broad Application to the Healing of Acute and Chronic Wounds".  // Biomedical Market Newsletter;5/7/2011, p92 

    The article evaluates ReCell® Spray-On Skin™, from Avita Medical Ltd., a regenerative medicine that been proven with potential broad application in treating acute and chronic wounds.

  • Financings roundup.  // Medical Device Daily;6/27/2011, Vol. 15 Issue 118, p3 

    The article reports on a closing by Avita Medical of the placement of its capital raising deal disclosed on May 17, 2011.

  • Avita Medical Reports Additional Market Acceptance of its ReCell(r) Spray-On-Skin(tm).  // Biomedical Market Newsletter;6/19/2011, p1039 

    The article reports on the introduction of ReCell Spray-On-Skin by Avita Medical Ltd. It says that ReCell was presented at the Cosmedica 2011 Congress for Aesthetic & Surgical Medicine in Bochum, Germany. It cites that a workshop procedure using ReCell with a carbon dioxide fractional laser was...

  • Avita Medical Sponsors Inaugural Skin Regeneration Symposium.  // Biomedical Market Newsletter;4/1/2012, Vol. 21, p1 

    The article provides information on the inaugural Skin Regeneration Symposium sponsored by Avita Medical Ltd. that was held from March 23-24, 2012 in Rome, Italy. The symposium was aimed for expert users of ReCell (®) Spray-On Skin (®) to present their research and findings in skin...

  • Avita Medical Initiates Trading on US OTCQX.  // Biomedical Market Newsletter;4/1/2012, Vol. 21, p1 

    The article reports on the trading of the American depositary receipts initiated by the regenerative medical company Avita Medical Ltd. on the OTCQX Markets Group Inc. of the U.S. Trading on the OTCQX marketplace provides helps the U.S. investors of the company with a direct market for...

  • Avita Medical Reports Third Quarter- and Nine-Month Financial Results.  // Biomedical Market Newsletter;5/5/2011, p112 

    The article reports that Avita Medical Ltd., a regenerative medicine company, has released its financial results for the 3rd quarter and nine months ending, ending March 31, 2011, in Great Britain. According to William Dolphin, chief executive officer (CEO) of Avita Medical, the sales of their...

  • Regenerative medicine working wonders. Bauckman, Chelsea // Soldiers;May2011, Vol. 66 Issue 5, p28 

    The article discusses the U.S. Armed Forces Institute of Regenerative Medicine (AFIRM) and its studies on the feats of regeneration that the human body is capable of. AFIRM is reported to aim at speeding up regenerative medicine therapies and technologies to help heal the wounded soldiers...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics